Skip navigation

Grifols SA

Pharmaceuticals
Spain
2016 Revenue (US$ Millions)$4,276
Revenue Growth (%)2.93%
Net Income (US$ Millions)$576
Earnings Per Share (US$)$0.84
EPS Growth Rate (%)2.56%
Profit Margin13.47%
Total Equity (US$ Millions)$3,929
Return on Equity (%)16.55%
Long Term Debt (US$ Millions)$0
Debt To Equity Ratio (%)0.00%
Total Assets (US$ Millions)$10,696
Current Assets (US$ Millions)$3,297
Current Liabilities (US$ Millions)$1,132
Cost of Goods Sold (US$ Millions)$2,257
Inventory Turnover1.39